Learn More
The prevalence of JAK2V617F tyrosine kinase mutation differs between various variants of myelofibrosis with the higher detection rate for patients with post-polycythemia vera myelofibrosis (post-PV(More)
Pre-existing anti-RhD-alloantibodies in allogeneic bone marrow donors are relatively seldom observed and may lead to hemolytic post transplant complications in RhDmismatched recipients. We describe(More)
  • 1